Universidad Católica San Antonio de Murcia
Murcia, Principality of Asturias, 33006, Spain
NCT Number: NCT06894537
Introduction. Variables such as pain and strength can be modified in the short and medium term by the application of currents. The percutaneous form of percutaneous needle-guided acupuncture can eliminate the impedance of the surrounding tissues that limit the optimal diffusion of the current to the target tissue. It is necessary to objectify the metabolic response of this technique and its effects in terms of strength and metabolic response.
Objective. To evaluate the safety and efficacy, in acute and subacute phases, of percutaneous electrical nerve stimulation in healthy subjects.
Method. Single-blind randomised clinical study. Thirty-two subjects will be recruited and randomised to the experimental and control groups. The intervention in the experimental group will consist of a percutaneous percutaneous electrical nerve stimulation of the femoral nerve, while in the control group the same intervention will be performed without increasing the intensity of the current. The primary variable will be vertical jump height (My Jump® iOS app) and the secondary variable will be skin temperature (Hikmicro M60 model Hangzhou).
Looking for future studies?
Notify Me18 year–24 year
All sexes
Interventional
Not applicable
Murcia, Principality of Asturias, 33006, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The protocol applied in this study will consist of: 10 stimulations of 10 seconds at 10Hz with a rest of 10 seconds between one stimulation and the next one. The intensity of the current (mA) will be adapted to each of the subjects until the greatest possible muscle contraction is achieved without reaching the painful threshold.
For the subjects in the control group, the same process shall be carried out without increasing the intensity of the current. It shall be explained to the subjects that the current will reach a non-perceptible stimulus.
Time frame: Baseline, within the first seven days after warming, treatment and after 1 and 24 hours follow-up visit
Using the My Jump® application (iOS app), the jump height is evaluated. This tool measures the time in the air (in milliseconds), indirectly assessing the height of the jump (in centimetres). This tool has shown a high reliability in the evaluation of counter movement jump. The unit of measurement is centimetres (cm), where the higher the centimetres, the higher the jump height.
Time frame: Baseline, within the first seven days after warming, treatment and after 1 and 24 hours follow-up visit
The metabolic response will be measured with a thermography device (Hikmicro M60 model Hangzhou camera). This complementary imaging technique analyses infrared radiation emitted by object surfaces (skin) and reflects the state of molecular agitation, providing objective information on the metabolic state of the underlying structures. The assessment shall be performed according to the consensus document on control variables in thermographic assessment.
Universidad Católica San Antonio de Murcia
Other
Efficacy of Echo-guided Percutaneous Electrical Nerve Stimulation of the Femoral Nerve on Explosive Strength and Metabolic Response in Healthy Subjects. A Randomised Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07166783
Health Subjects
View Trial DetailsNCT07166796
Health Subjects
View Trial DetailsNCT06724549
Health Subjects
Changsha, Hunan, China
View Trial DetailsNCT04932252
Health Subjects
Seoul, South Korea
View Trial Details